The 4 bullish ratings from analysts in the last quarter indicate a positive sentiment towards Renalytix's stock. However, the average 12-month price target of $4.62 represents a 23.0% decrease from the previous target, which may cause some investors to reconsider their positions. The high relevance and importance of this news for RNLX investors, combined with a high confidence in the analysis, suggest a likely short-term positive impact on the stock price.